Your browser doesn't support javascript.
loading
Gantenerumab: a novel human anti-Aß antibody demonstrates sustained cerebral amyloid-ß binding and elicits cell-mediated removal of human amyloid-ß.
Bohrmann, Bernd; Baumann, Karlheinz; Benz, Jörg; Gerber, Francoise; Huber, Walter; Knoflach, Frédéric; Messer, Jürg; Oroszlan, Krisztina; Rauchenberger, Robert; Richter, Wolfgang F; Rothe, Christine; Urban, Margit; Bardroff, Michael; Winter, Michael; Nordstedt, Christer; Loetscher, Hansruedi.
Affiliation
  • Bohrmann B; F. Hoffmann-La Roche Ltd., pRED, Basel, Switzerland. bernd.bohrmann@roche.com
J Alzheimers Dis ; 28(1): 49-69, 2012.
Article in En | MEDLINE | ID: mdl-21955818
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amyloid beta-Peptides / Antibodies, Monoclonal, Humanized / Antibodies, Monoclonal Limits: Animals / Female / Humans / Male Language: En Journal: J Alzheimers Dis Journal subject: GERIATRIA / NEUROLOGIA Year: 2012 Document type: Article Affiliation country: Switzerland Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amyloid beta-Peptides / Antibodies, Monoclonal, Humanized / Antibodies, Monoclonal Limits: Animals / Female / Humans / Male Language: En Journal: J Alzheimers Dis Journal subject: GERIATRIA / NEUROLOGIA Year: 2012 Document type: Article Affiliation country: Switzerland Country of publication: Netherlands